Cargando…
Recurrent thrombosis rescued by fondaparinux in high‐risk patients: A case series
BACKGROUND: Recurrent thrombosis treatment options are limited when anticoagulation with dose escalation of low molecular weight heparin or unfractionated heparin fail. Fondaparinux is a pure, synthetic pentasaccharide that consists of heparin's essential five‐sugar chain that binds antithrombi...
Autores principales: | Tanguay, Mégane, Séguin, Chantal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336207/ https://www.ncbi.nlm.nih.gov/pubmed/35919877 http://dx.doi.org/10.1002/rth2.12773 |
Ejemplares similares
-
The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018) -
Extensive deep vein thrombosis treatment using fondaparinux and edoxaban: a case report
por: Shimizu, Kazuhiro, et al.
Publicado: (2016) -
Argatroban /AZD-1222/fondaparinux-sodium: Vaccine-induced immune thrombosis with thrombocytopenia and recurrent and fatal intracranial haemorrhage: case report
Publicado: (2021) -
Anticoagulant therapy with fondaparinux in a liver transplant patient with thrombosis and liver fibrosis: a case report
por: Cafolla, Arturo, et al.
Publicado: (2017) -
Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)